In a large trial, screening yearly for lung cancer hasn't reduced mortality rates. Why is this? Isn't cancer best treatable when caught early? Is this because lung cancer is hard to treat anyway, because yearly is not frequent enough, or why?
Tell me more
×
Biology Stack Exchange is a question and answer site for
biology researchers, academics, and students. It's 100% free, no registration required.
|
There are a number of reasons, generally, why a screening test may fail to decrease cancer mortality rates:
In this case it appears that a chest radiograph isn't good enough at detecting lung cancer to manifestly improve mortality outcomes. The author's of the paper don't really specify why this is - though since they're just looking at lung cancer mortality, it's likely not #2. |
|||
|
|
Diagnostic follow-up of positive screening results was determined by participants and their health care practitioners-- essentially, this leaves what to actually do with the positive result to the patient and/or the doctor. Some patients may refuse care and some doctors may not be equipped to deal with the problem or hesitate to farm out to specialists. – jonsca May 8 '12 at 4:58